Breaking News Instant updates and real-time market news.

RHHBY

Roche

$0.00

(0.00%)

05:24
12/10/18
12/10
05:24
12/10/18
05:24

Roche CEO Daniel O'Day to step down, Genentech CEO William Anderson to succeed

Roche (RHHBY) announced that Daniel O'Day, CEO Roche Pharmaceuticals and member of the Corporate Executive Committee, will be stepping down from his role as of December 31, 2018. Until the end of February 2019 and prior to assuming new responsibilities outside of Roche, he will provide his support to ensure a smooth transition of activities. William Anderson, currently CEO of Genentech, will be appointed CEO Roche Pharmaceuticals effective January 1, 2019. He will be based in Basel, report to Severin Schwan, Roche Group CEO and become a member of the Corporate Executive Committee.

  • 11

    Dec

  • 24

    Dec

  • 18

    Mar

RHHBY Roche
$0.00

(0.00%)

11/26/18
SBSH
11/26/18
NO CHANGE
SBSH
Citi opens positive catalyst watch on Roche
Citi analyst Andrew Baum opened a positive catalyst watch on Roche (RHHBY) shares saying he expects CD20-TCB data at the American Society of Hematology meeting to report overall response rate and complete response "materially higher" than the 38% and 24% reported in the abstract as doses are escalated from 1800 microgams up to 60 milligrams. Further, unlike the Genentech and Regeneron (REGN) antibodies, Roche has seen no neurotoxicity with their CD20-TCB, says Baum. The analyst anticipates that Roche's CD20-TCB will look superior to Genentech's CD20/CD3 and Regeneron's REGN1979 on safety. He keeps a Neutral rating on Roche.
11/19/18
GSCO
11/19/18
DOWNGRADE
GSCO
Buy
Roche downgraded to Buy from Conviction Buy at Goldman Sachs
Goldman Sachs analyst Katherine Alexakis removed Roche from her firm's Conviction List but keeps a Buy rating on the shares. A number of "sentiment overhangs" in the near-term, namely the launch of U.S. biosimilars, combined with a lack of tangible catalysts could limit share upside, says the analyst.
11/19/18
WELS
11/19/18
NO CHANGE
WELS
Pfizer price hikes may bring industry scrutiny, says Wells Fargo
Pfizer's (PFE) plans to raise prices on a host of medicines may put the drug industry "further in the crosshairs of an administration and Congress that is set on lowering drug prices," Wells Fargo analyst David Maris tells investors in a research note. The analyst points out that Pfizer earlier this year was criticized by the Trump administration for drug price increases, and as a result, it rolled the price increases back. However, Pfizer's new price increases "are not egregious" and its advance warning may be an attempt to see if minor price increases will also bring the administration's rebuke, says Maris. Nonetheless, given how public the administration's previous rebuke was, the analyst thinks Pfizer's confirmation Friday could "enflame the debate around drug pricing, especially since it comes less than two weeks following an election that resulted in Democrat control of the House with many having run on a drug-price-controls/Medicare-for-All platforms." Other large drugmakers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Roche (RHHBY) and Sanofi (SNY).
11/13/18
LEER
11/13/18
INITIATION
Target $18
LEER
Outperform
AC Immune initiated with an Outperform at Leerink
Leerink analyst Marc Goodman started AC Immune with an Outperform and $18 price target as he initiates Neuroscience space with a Positive View. The analyst believes the Neuroscience sector is experiencing a "renaissance" as multiple new agents and mechanisms are coming up the pipeline across major therapeutic areas, the number of clinical studies is growing nicely, and the FDA is friendly to innovation in this space, companies are getting smarter about speed-to-market strategies and selecting niche sub-populations to focus on for initial product approvals, payer pushback on usage is much lower than in other categories, and physicians are enthusiastic about new agents. Regarding AC Immune, Goodman notes that it has a diversified pipeline of drug candidates and diagnostics for Alzheimer's disease led by a late stage antibody with crenezumab, and has strong partners with Roche (RHHBY) for crenezumab, Johnson & Johnson (JNJ) for Anti-Tau vaccine, Biogen (BIIB) for alphasynuclein-PET tracer diagnostic, and Piramal for TauPET tracer diagnostic.

TODAY'S FREE FLY STORIES

QCOM

Qualcomm

$90.48

0.03 (0.03%)

, AAPL

Apple

$262.66

-1.86 (-0.70%)

04:59
11/15/19
11/15
04:59
11/15/19
04:59
Upgrade
Qualcomm upgraded to Buy from Neutral at Mizuho »

Mizuho analyst Vijay…

QCOM

Qualcomm

$90.48

0.03 (0.03%)

AAPL

Apple

$262.66

-1.86 (-0.70%)

SSNLF

Samsung

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Nov

NUE

Nucor

$54.49

-0.2 (-0.37%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Nucor management to meet with KeyBanc »

Management participates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

INS

Intelligent Systems

$42.26

-0.34 (-0.80%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Intelligent Systems management to meet with Sidoti »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EXPI

eXp World Holdings

$9.97

-0.08 (-0.80%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
eXp World Holdings management to meet with DA Davidson »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

GSHD

Goosehead Insurance

$44.75

0.02 (0.04%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Goosehead Insurance management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 03

    Dec

04:55
11/15/19
11/15
04:55
11/15/19
04:55
General news
Industrial Production Capacity Utilization Rate to be reported at 09:15 »

October Industrial…

04:55
11/15/19
11/15
04:55
11/15/19
04:55
General news
Business Inventories to be reported at 10:00 »

September Business…

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
CLSA to hold a forum »

22nd CLSA India Forum…

04:55
11/15/19
11/15
04:55
11/15/19
04:55
General news
Breaking General news story  »

Week of 11/15…

TRGP

Targa Resources

$38.03

-0.28 (-0.73%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Targa Resources management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

UBX

Unity Biotechnology

$6.30

-0.26 (-3.96%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Unity Biotechnology management to meet with Mizuho »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 13

    Dec

CTSO

CytoSorbents

$4.24

-0.2 (-4.50%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
CytoSorbents management to meet with B. Riley FBR »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

FTNT

Fortinet

$100.07

0.38 (0.38%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Fortinet management to meet with MKM Partners »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 18

    Nov

  • 19

    Nov

  • 05

    Dec

  • 06

    Dec

  • 09

    Dec

  • 12

    Dec

LNDC

Landec

$11.05

0.195 (1.80%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Landec management to meet with DA Davidson »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 15

    Nov

SPR

Spirit AeroSystems

$89.60

0.31 (0.35%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Spirit AeroSystems management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Wolfe Research tech strategist to hold analyst/industry webcast »

Tech Strategist…

DTIL

Precision BioSciences

$11.80

2.33 (24.60%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Precision BioSciences participates in a conference call with BTIG »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 07

    Dec

MPWR

Monolithic Power

$159.94

-0.51 (-0.32%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Monolithic Power management to meet with Oppenheimer »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 20

    Nov

CNI

Canadian National

$93.18

0.32 (0.34%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Canadian National management to meet with RBC Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 21

    Nov

  • 22

    Nov

ESTA

Establishment Labs

$23.74

0.06 (0.25%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Establishment Labs management to meet with Jefferies »

Meetings to be held…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

EA

Electronic Arts

$97.54

1.52 (1.58%)

, MSFT

Microsoft

$148.06

0.73 (0.50%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Oppenheimer to hold a bus tour »

Gaming Bus Tour travels…

EA

Electronic Arts

$97.54

1.52 (1.58%)

MSFT

Microsoft

$148.06

0.73 (0.50%)

ZNGA

Zynga

$6.33

0.005 (0.08%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Nov

  • 04

    Dec

  • 09

    Dec

NOVA

Sunnova Energy

$10.60

0.745 (7.56%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Sunnova Energy management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 09

    Dec

AAN

Aaron's

$58.85

2.05 (3.61%)

, BSX

Boston Scientific

$41.57

0.16 (0.39%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Stephens to hold a conference »

2019 Stephens Nashville…

AAN

Aaron's

$58.85

2.05 (3.61%)

BSX

Boston Scientific

$41.57

0.16 (0.39%)

CBM

Cambrex

$59.86

(0.00%)

CNI

Canadian National

$93.18

0.32 (0.34%)

EA

Electronic Arts

$97.54

1.52 (1.58%)

DPZ

Domino's Pizza

$278.68

-0.555 (-0.20%)

ENSG

Ensign Group

$40.68

0.37 (0.92%)

EGOV

NIC Inc.

$23.61

0.2 (0.85%)

FIS

FIS

$135.49

1.68 (1.26%)

FDX

FedEx

$156.72

0.5 (0.32%)

EXP

Eagle Materials

$93.76

1.215 (1.31%)

EPAY

Bottomline Technologies

$46.95

0.71 (1.54%)

GKOS

Glaukos

$62.68

(0.00%)

GMS

GMS Inc.

$32.07

0.72 (2.30%)

HAL

Halliburton

$20.33

-0.29 (-1.41%)

HUM

Humana

$317.95

-0.94 (-0.29%)

JAX

J. Alexander's

$10.45

0.02 (0.19%)

JBHT

J.B. Hunt

$116.81

0.27 (0.23%)

LAD

Lithia Motors

$160.86

-0.34 (-0.21%)

LII

Lennox

$254.96

2.6 (1.03%)

LPX

Louisiana-Pacific

$29.10

-0.14 (-0.48%)

MATX

Matson

$36.65

-0.48 (-1.29%)

MOS

Mosaic

$20.30

0.61 (3.10%)

ODFL

Old Dominion

$195.17

0.58 (0.30%)

VG

Vonage

$7.68

-0.13 (-1.66%)

UNT

Unit Corp.

$0.79

-0.1114 (-12.38%)

WMT

Walmart

$120.65

-0.41 (-0.34%)

WNC

Wabash

$14.91

-0.255 (-1.68%)

RM

Regional Management

$33.09

0.31 (0.95%)

POOL

Pool Corp.

$205.52

0.74 (0.36%)

SAVE

Spirit Airlines

$37.70

0.21 (0.56%)

SLB

Schlumberger

$34.72

-0.31 (-0.88%)

SM

SM Energy

$8.88

-0.34 (-3.69%)

NTR

Nutrien

$49.30

-0.13 (-0.26%)

NOV

National Oilwell

$22.09

-0.26 (-1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 19

    Nov

  • 21

    Nov

  • 21

    Nov

  • 22

    Nov

  • 09

    Dec

  • 09

    Dec

  • 11

    Dec

  • 11

    Dec

  • 12

    Dec

  • 17

    Dec

  • 07

    Feb

SERV

ServiceMaster

$34.00

-0.115 (-0.34%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
ServiceMaster management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

AMZN

Amazon.com

$1,754.71

0.87 (0.05%)

04:55
11/15/19
11/15
04:55
11/15/19
04:55
Conference/Events
Amazon.com management to meet with Loop Capital »

Management has a tour of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

  • 19

    Nov

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.